These investigators further demonstrated that CD4+ T cells, CD8+ T cells, or a combination of both, derived from DTA-1 treated tumor-challenged mice, led to tumor rejection following adoptive transfer in their model system. The gene discussed is CD4; the disease is neoplasm.